Healthcare

Small Molecule API Market Size Analysis 2022 To 2030

The global small molecule API market size accounted for US$ 179.62 billion in 2021 and is projected to reach around USD 293.56 billion by 2030, growing at a CAGR of 5.61% from 2022 to 2030.

Small Molecule API Market Key Takeaways:

  • By therapeutic area, oncology segment has accounted 26.9% of market share in 2021.
  • By type, the synthetic API has contributed highest market share of around 79.9% in 2021.
  • North America has contributed 33% of total revenue share in 2021.
Small Molecule API Market Size 2022 To 2030

 

Report Summary

The global small molecule API market report provides a Point-by-Point and In-Depth analysis of global market size, regional and country-level market size, market share, segmentation market growth, competitive landscape, sales analysis, opportunities analysis, strategic market growth analysis, the impact of domestic and global market key players, value chain optimization, trade regulations, recent developments, product launches, area marketplace expanding, and technological innovations.

The study offers a comprehensive analysis on diverse features, including production capacities, demand, product developments, revenue generation, and sales in the small molecule API market across the globe.

A comprehensive estimate on the small molecule API market has been provided through an optimistic scenario as well as a conservative scenario, taking into account the sales of small molecule API during the forecast period. Price point comparison by region with global average price is also considered in the study.

Report CoverageDetails
Market Size in 2022USD 189.7 Billion
Market Size by 2030USD 293.56 Billion
Growth Rate from 2022 to 2030CAGR of 5.61%
Base Year2021
Forecast Period2022 to 2030
Segments CoveredType, Manufacturer, Application, Therapeutic Sector, Application, and Geography

Key Highlights:

Reports Coverage: It incorporates key market sections, key makers secured, the extent of items offered in the years considered, worldwide containerized small molecule API market and study goals. Moreover, it contacts the division study gave in the report based on the sort of item and applications.

Market Outline: This area stresses the key investigations, market development rate, serious scene, market drivers, patterns, and issues notwithstanding the naturally visible pointers.

Market Production by Region: The report conveys information identified with import and fare, income, creation, and key players of every single local market contemplated are canvassed right now.

Also Read: Medical Grade Silicone Market Size Analysis 2022 To 2030

Small Molecule API Market Players

The report includes the profiles of key small molecule API market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information, key development in past five years.

Major companies operating in this area are BASF SE, Gilead Sciences, Inc, Johnson Matthey, Teva Pharmaceutical Industries Ltd, Sun Pharmaceutical Industries Ltd, Siegfried Holding AG, Pfizer, Novartis AG, Merck KGaA, Lonza, GSk plc, Dr. Reddy’s Laboratories Ltd, Cambrex Corporation, Allergan, Albemarle Corporation, Hoffmann-La Roche Ltd, AstraZeneca, Albany Molecular Research Inc., Sanofi S.A, Baxter International Inc, Celgene Corporation, Boehringer Ingelheim International GmbH

Market Segmentation

By Type

  • Synthetic
  • Biological

By Manufacturer

  • In-house
  • Outsourced

By Application

  • Clinical
  • Commercial

By Therapeutic Sector

  • Cardiovascular
  • Oncology
  • CNS and Neurology
  • Pulmonology
  • Endocrinology
  • Gastroentrology
  • Nephrology
  • Orthopedic
  • Gynecological
  • Opthalmic
  • Dermatology
  • Urology
  • Immunology
  • Respiratory disorders
  • Cosmetic and plastic
  • General surgery
  • Others

By Application

Regional Segmentation

  • North America (U.S., Canada, Mexico)
  • Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
  • Asia-Pacific (China, Japan, India, Southeast Asia and Rest of APAC)
  • Latin America (Brazil and Rest of Latin America)
  • Middle East and Africa (GCC, North Africa, South Africa, Rest of MEA)

Research Methodology

Secondary Research

It involves company databases such as Hoover’s: This assists us to recognize financial information, the structure of the market participants and industry’s competitive landscape.

The secondary research sources referred in the process are as follows:

  • Governmental bodies, and organizations creating economic policies
  • National and international social welfare institutions
  • Company websites, financial reports and SEC filings, broker and investor reports
  • Related patent and regulatory databases
  • Statistical databases and market reports
  • Corporate Presentations, news, press release, and specification sheet of Manufacturers

Primary Research

Primary research includes face-to-face interviews, online surveys, and telephonic interviews.

  • Means of primary research: Email interactions, telephonic discussions and Questionnaire-based research etc.
  • In order to validate our research findings and analysis, we conduct primary interviews of key industry participants. Insights from primary respondents help in validating the secondary research findings. It also develops Research Team’s expertise and market understanding.

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Small Molecule API Market 

5.1. COVID-19 Landscape: Small Molecule API Industry Impact

5.2. COVID 19 – Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Small Molecule API Market, By Type

8.1. Small Molecule API Market, by Type, 2022-2030

8.1.1. Synthetic

8.1.1.1. Market Revenue and Forecast (2017-2030)

8.1.2. Biological

8.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global Small Molecule API Market, By Manufacturer

9.1. Small Molecule API Market, by Manufacturer, 2022-2030

9.1.1. In-house

9.1.1.1. Market Revenue and Forecast (2017-2030)

9.1.2. Outsourced

9.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 10. Global Small Molecule API Market, By Application 

10.1. Small Molecule API Market, by Application, 2022-2030

10.1.1. Clinical

10.1.1.1. Market Revenue and Forecast (2017-2030)

10.1.2. Commercial

10.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 11. Global Small Molecule API Market, By Therapeutic Sector

11.1. Small Molecule API Market, by Therapeutic Sector, 2022-2030

11.1.1. Cardiovascular

11.1.1.1. Market Revenue and Forecast (2017-2030)

11.1.2. Oncology

11.1.2.1. Market Revenue and Forecast (2017-2030)

11.1.3. CNS and Neurology

11.1.3.1. Market Revenue and Forecast (2017-2030)

11.1.4. Pulmonology

11.1.4.1. Market Revenue and Forecast (2017-2030)

11.1.5. Endocrinology

11.1.5.1. Market Revenue and Forecast (2017-2030)

11.1.6. Gastroentrology

11.1.6.1. Market Revenue and Forecast (2017-2030)

11.1.7. Nephrology

11.1.7.1. Market Revenue and Forecast (2017-2030)

11.1.8. Orthopedic

11.1.8.1. Market Revenue and Forecast (2017-2030)

11.1.9. Gynecological

11.1.9.1. Market Revenue and Forecast (2017-2030)

11.1.10. Opthalmic

11.1.10.1. Market Revenue and Forecast (2017-2030)

11.1.11. Dermatology

11.1.11.1. Market Revenue and Forecast (2017-2030)

11.1.12. Urology

11.1.12.1. Market Revenue and Forecast (2017-2030)

11.1.13. Immunology

11.1.13.1. Market Revenue and Forecast (2017-2030)

11.1.14. Respiratory disorders

11.1.14.1. Market Revenue and Forecast (2017-2030)

11.1.15. Cosmetic and plastic

11.1.15.1. Market Revenue and Forecast (2017-2030)

11.1.16. General surgery

11.1.16.1. Market Revenue and Forecast (2017-2030)

11.1.17. Others

11.1.17.1. Market Revenue and Forecast (2017-2030)

Chapter 12. Global Small Molecule API Market, By Application

12.1. Small Molecule API Market, by Application, 2022-2030

12.1.1. Hospitals

12.1.1.1. Market Revenue and Forecast (2017-2030)

12.1.2. Ambulatory Surgery center

12.1.2.1. Market Revenue and Forecast (2017-2030)

12.1.3. Health clinics

12.1.3.1. Market Revenue and Forecast (2017-2030)

12.1.4. Others

12.1.4.1. Market Revenue and Forecast (2017-2030)

Chapter 13. Global Small Molecule API Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Forecast, by Type (2017-2030)

13.1.2. Market Revenue and Forecast, by Manufacturer (2017-2030)

13.1.3. Market Revenue and Forecast, by Application (2017-2030)

13.1.4. Market Revenue and Forecast, by Therapeutic Sector (2017-2030)

13.1.5. Market Revenue and Forecast, by Application (2017-2030)

13.1.6. U.S.

13.1.6.1. Market Revenue and Forecast, by Type (2017-2030)

13.1.6.2. Market Revenue and Forecast, by Manufacturer (2017-2030)

13.1.6.3. Market Revenue and Forecast, by Application (2017-2030)

13.1.6.4. Market Revenue and Forecast, by Therapeutic Sector (2017-2030)

13.1.6.5. Market Revenue and Forecast, by Application (2017-2030)

13.1.7. Rest of North America

13.1.7.1. Market Revenue and Forecast, by Type (2017-2030)

13.1.7.2. Market Revenue and Forecast, by Manufacturer (2017-2030)

13.1.7.3. Market Revenue and Forecast, by Application (2017-2030)

13.1.7.4. Market Revenue and Forecast, by Therapeutic Sector (2017-2030)

13.1.7.5. Market Revenue and Forecast, by Application (2017-2030)

13.2. Europe

13.2.1. Market Revenue and Forecast, by Type (2017-2030)

13.2.2. Market Revenue and Forecast, by Manufacturer (2017-2030)

13.2.3. Market Revenue and Forecast, by Application (2017-2030)

13.2.4. Market Revenue and Forecast, by Therapeutic Sector (2017-2030)

13.2.5. Market Revenue and Forecast, by Application (2017-2030)

13.2.6. UK

13.2.6.1. Market Revenue and Forecast, by Type (2017-2030)

13.2.6.2. Market Revenue and Forecast, by Manufacturer (2017-2030)

13.2.6.3. Market Revenue and Forecast, by Application (2017-2030)

13.2.7. Market Revenue and Forecast, by Therapeutic Sector (2017-2030)

13.2.8. Market Revenue and Forecast, by Application (2017-2030)

13.2.9. Germany

13.2.9.1. Market Revenue and Forecast, by Type (2017-2030)

13.2.9.2. Market Revenue and Forecast, by Manufacturer (2017-2030)

13.2.9.3. Market Revenue and Forecast, by Application (2017-2030)

13.2.10. Market Revenue and Forecast, by Therapeutic Sector (2017-2030)

13.2.11. Market Revenue and Forecast, by Application (2017-2030)

13.2.12. France

13.2.12.1. Market Revenue and Forecast, by Type (2017-2030)

13.2.12.2. Market Revenue and Forecast, by Manufacturer (2017-2030)

13.2.12.3. Market Revenue and Forecast, by Application (2017-2030)

13.2.12.4. Market Revenue and Forecast, by Therapeutic Sector (2017-2030)

13.2.13. Market Revenue and Forecast, by Application (2017-2030)

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Forecast, by Type (2017-2030)

13.2.14.2. Market Revenue and Forecast, by Manufacturer (2017-2030)

13.2.14.3. Market Revenue and Forecast, by Application (2017-2030)

13.2.14.4. Market Revenue and Forecast, by Therapeutic Sector (2017-2030)

13.2.15. Market Revenue and Forecast, by Application (2017-2030)

13.3. APAC

13.3.1. Market Revenue and Forecast, by Type (2017-2030)

13.3.2. Market Revenue and Forecast, by Manufacturer (2017-2030)

13.3.3. Market Revenue and Forecast, by Application (2017-2030)

13.3.4. Market Revenue and Forecast, by Therapeutic Sector (2017-2030)

13.3.5. Market Revenue and Forecast, by Application (2017-2030)

13.3.6. India

13.3.6.1. Market Revenue and Forecast, by Type (2017-2030)

13.3.6.2. Market Revenue and Forecast, by Manufacturer (2017-2030)

13.3.6.3. Market Revenue and Forecast, by Application (2017-2030)

13.3.6.4. Market Revenue and Forecast, by Therapeutic Sector (2017-2030)

13.3.7. Market Revenue and Forecast, by Application (2017-2030)

13.3.8. China

13.3.8.1. Market Revenue and Forecast, by Type (2017-2030)

13.3.8.2. Market Revenue and Forecast, by Manufacturer (2017-2030)

13.3.8.3. Market Revenue and Forecast, by Application (2017-2030)

13.3.8.4. Market Revenue and Forecast, by Therapeutic Sector (2017-2030)

13.3.9. Market Revenue and Forecast, by Application (2017-2030)

13.3.10. Japan

13.3.10.1. Market Revenue and Forecast, by Type (2017-2030)

13.3.10.2. Market Revenue and Forecast, by Manufacturer (2017-2030)

13.3.10.3. Market Revenue and Forecast, by Application (2017-2030)

13.3.10.4. Market Revenue and Forecast, by Therapeutic Sector (2017-2030)

13.3.10.5. Market Revenue and Forecast, by Application (2017-2030)

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Forecast, by Type (2017-2030)

13.3.11.2. Market Revenue and Forecast, by Manufacturer (2017-2030)

13.3.11.3. Market Revenue and Forecast, by Application (2017-2030)

13.3.11.4. Market Revenue and Forecast, by Therapeutic Sector (2017-2030)

13.3.11.5. Market Revenue and Forecast, by Application (2017-2030)

13.4. MEA

13.4.1. Market Revenue and Forecast, by Type (2017-2030)

13.4.2. Market Revenue and Forecast, by Manufacturer (2017-2030)

13.4.3. Market Revenue and Forecast, by Application (2017-2030)

13.4.4. Market Revenue and Forecast, by Therapeutic Sector (2017-2030)

13.4.5. Market Revenue and Forecast, by Application (2017-2030)

13.4.6. GCC

13.4.6.1. Market Revenue and Forecast, by Type (2017-2030)

13.4.6.2. Market Revenue and Forecast, by Manufacturer (2017-2030)

13.4.6.3. Market Revenue and Forecast, by Application (2017-2030)

13.4.6.4. Market Revenue and Forecast, by Therapeutic Sector (2017-2030)

13.4.7. Market Revenue and Forecast, by Application (2017-2030)

13.4.8. North Africa

13.4.8.1. Market Revenue and Forecast, by Type (2017-2030)

13.4.8.2. Market Revenue and Forecast, by Manufacturer (2017-2030)

13.4.8.3. Market Revenue and Forecast, by Application (2017-2030)

13.4.8.4. Market Revenue and Forecast, by Therapeutic Sector (2017-2030)

13.4.9. Market Revenue and Forecast, by Application (2017-2030)

13.4.10. South Africa

13.4.10.1. Market Revenue and Forecast, by Type (2017-2030)

13.4.10.2. Market Revenue and Forecast, by Manufacturer (2017-2030)

13.4.10.3. Market Revenue and Forecast, by Application (2017-2030)

13.4.10.4. Market Revenue and Forecast, by Therapeutic Sector (2017-2030)

13.4.10.5. Market Revenue and Forecast, by Application (2017-2030)

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Forecast, by Type (2017-2030)

13.4.11.2. Market Revenue and Forecast, by Manufacturer (2017-2030)

13.4.11.3. Market Revenue and Forecast, by Application (2017-2030)

13.4.11.4. Market Revenue and Forecast, by Therapeutic Sector (2017-2030)

13.4.11.5. Market Revenue and Forecast, by Application (2017-2030)

13.5. Latin America

13.5.1. Market Revenue and Forecast, by Type (2017-2030)

13.5.2. Market Revenue and Forecast, by Manufacturer (2017-2030)

13.5.3. Market Revenue and Forecast, by Application (2017-2030)

13.5.4. Market Revenue and Forecast, by Therapeutic Sector (2017-2030)

13.5.5. Market Revenue and Forecast, by Application (2017-2030)

13.5.6. Brazil

13.5.6.1. Market Revenue and Forecast, by Type (2017-2030)

13.5.6.2. Market Revenue and Forecast, by Manufacturer (2017-2030)

13.5.6.3. Market Revenue and Forecast, by Application (2017-2030)

13.5.6.4. Market Revenue and Forecast, by Therapeutic Sector (2017-2030)

13.5.7. Market Revenue and Forecast, by Application (2017-2030)

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Forecast, by Type (2017-2030)

13.5.8.2. Market Revenue and Forecast, by Manufacturer (2017-2030)

13.5.8.3. Market Revenue and Forecast, by Application (2017-2030)

13.5.8.4. Market Revenue and Forecast, by Therapeutic Sector (2017-2030)

13.5.8.5. Market Revenue and Forecast, by Application (2017-2030)

Chapter 14. Company Profiles

14.1. BASF SE

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. Gilead Sciences, Inc

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. Johnson Matthey

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. Teva Pharmaceutical Industries Ltd

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. Sun Pharmaceutical Industries Ltd

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. Siegfried Holding AG

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. Pfizer

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

14.8. Novartis AG

14.8.1. Company Overview

14.8.2. Product Offerings

14.8.3. Financial Performance

14.8.4. Recent Initiatives

14.9. Merck KGaA

14.9.1. Company Overview

14.9.2. Product Offerings

14.9.3. Financial Performance

14.9.4. Recent Initiatives

14.10. Lonza

14.10.1. Company Overview

14.10.2. Product Offerings

14.10.3. Financial Performance

14.10.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms

Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.

Download Access to a Free Copy of Our Latest Sample Report@ https://www.precedenceresearch.com/sample/2215

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Emailsales@precedenceresearch.com

Web: https://www.precedenceresearch.com

Blog: https://precedenceresearchnews.wordpress.com

Show More

Precedence Research

Precedence Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings.

Related Articles

Back to top button